ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Other Working Capital

Cash effect of changes in other operating assets and liabilities.

No reported Other Working Capital figures are available to summarize.

Other Working Capital history

Currency unavailable · from the cash flow

No Other Working Capital data reported for this period type.

Other Working Capital vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Other Working Capital for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MGTXMeiraGTx Holdings plcLTM Mar 2026$94.98M USD+941.2%+304.5%119.1%
WVEWave Life Sciences Ltd.LTM Mar 2026$43.07M USD-54.4%+84.6%60.0%
STOKStoke Therapeutics, Inc.LTM Mar 2026$20.91M USD+15.2%—65.2%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$19.64M USD-71.6%+51.1%43.3%
PRQRProQR Therapeutics N.V.LTM Mar 2026€10.48M EUR-2.6%+49.7%78.0%
SLNSilence Therapeutics plcLTM Mar 2026$8.34M USD——905.3%
RNAAtrium Therapeutics, Inc.FY2025$3.93M USD——21.1%
PRMEPrime Medicine, Inc.LTM Mar 2026$2.87M USD-105.6%-44.9%71.1%
BNTCBenitec Biopharma Inc.LTM Mar 2026$998.82K USD+76.5%——
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-2.6%+51.1%68.1%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.